Therapeutics Inc.

Executive Summary

Therapeutics Inc. is a private, San Diego-based contract research organization (CRO) specializing in dermatology. Founded in 2012, the company offers integrated, turnkey solutions that guide clients from early non-clinical development through clinical trials and regulatory approval to commercialization. By navigating the complex maze of drug development hurdles, Therapeutics Inc. positions itself as a comprehensive partner for pharmaceutical and biotech companies seeking to bring dermatology products to market. The firm's focus on a single therapeutic area may limit diversification but allows deep expertise and efficient service delivery. As a privately held company with no disclosed funding or valuation, its financial standing is opaque, but its niche in dermatology CRO services could see steady demand given the growing pipeline of topical and systemic dermatological therapies. The company's profile remains low, with no public pipelines or recent catalysts, suggesting a need for greater visibility to attract clients and investors.

Upcoming Catalysts (preview)

• Q3 2026Major Pharma Partnership Announcement30% success
• Q4 2026Expansion into Adjacent Therapeutic Areas (e.g., Wound Healing)40% success
• Q2 2026FDA Approval or Milestone for a Client's Product Supported by Therapeutics Inc.25% success